UNSPSC 85813129: Introduction of anti-inflammatory into biliary and pancreatic tract, via natural or artificial opening

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of anti-inflammatory into biliary and pancreatic tract, via natural or artificial opening. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0J73Z

UNSPSC 85813129 — Introduction of anti-inflammatory into biliary and pancreatic tract via natural or artificial opening — is a Commodity code that shows no relevant recent state and local procurement activity. The recent opportunities tagged to this code span virtual urgent care services, medical services, PACE operations, cancer screening, occupational health, behavioral health treatment, EMS staffing, imaging devices, dental services, and various clinical support functions—none of which involve biliary or pancreatic anti-inflammatory drug administration. The code appears to describe a narrow clinical procedure or pharmaceutical delivery mechanism that state and local jurisdictions do not currently buy through open solicitation; if procurement exists under this code, it operates through channels not reflected in the recent opportunities block.

State and local health authorities, counties, and special-purpose districts are instead purchasing broad categories of occupational health services (pre-employment exams, drug screening, fitness-for-duty evaluations), crisis behavioral health response, intensive treatment programs, medical director oversight for EMS systems, and administrative health services. Issuing bodies include state health departments and commissions (Nevada Health Authority, Texas HHSC, Colorado Department of Human Services), county health systems and behavioral health departments (Santa Clara, Ventura, Jackson, Fairfax), public hospital systems (San Mateo Medical Center), and city and county agencies. The geographic spread spans California, Colorado, Florida, Georgia, Kansas, Missouri, Nevada, New Jersey, New York, Oregon, Texas, and Virginia. If your firm delivers anti-inflammatory drug administration services or related pharmaceutical interventions in clinical or surgical settings, this code offers limited pursuit opportunity in the current state and local procurement environment; instead, track broader occupational health, emergency medicine, and specialty clinical service codes where actual procurement demand exists.